TR200003801T2 - On-skin compositions and methods to relieve pain - Google Patents

On-skin compositions and methods to relieve pain

Info

Publication number
TR200003801T2
TR200003801T2 TR2000/03801T TR200003801T TR200003801T2 TR 200003801 T2 TR200003801 T2 TR 200003801T2 TR 2000/03801 T TR2000/03801 T TR 2000/03801T TR 200003801 T TR200003801 T TR 200003801T TR 200003801 T2 TR200003801 T2 TR 200003801T2
Authority
TR
Turkey
Prior art keywords
methods
relieve pain
skin compositions
compositions
invention describes
Prior art date
Application number
TR2000/03801T
Other languages
Turkish (tr)
Inventor
W. Murdock Robert
Donald Williams C.
Original Assignee
Pharmaceuticals Applications Asociates, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/106,684 external-priority patent/US6290986B1/en
Application filed by Pharmaceuticals Applications Asociates, Llc filed Critical Pharmaceuticals Applications Asociates, Llc
Publication of TR200003801T2 publication Critical patent/TR200003801T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Mevcut bulus, transdermal uygulama için olan yöntemleri ve bilesikleri anlatir. Bir uygulamada bulus, bifazik çözünürlüge sahip ve/veya bifazik çözünürlüge sahip olan bilesim içeren aminin etkinligini artiran bir amin bilesimin, örnegin kas gevsetici, agrinin hafifletilmesi için transdermal uygulamasi için olan yöntemleri ve bilesikleri anlatir.The present invention describes methods and compounds for transdermal administration. In one embodiment, the invention describes methods and compositions for the administration of an amine composition that enhances the activity of the amine containing biphasic solubility and / or biphasic solubility, for example muscle relaxant, pain relief.

TR2000/03801T 1998-06-29 1999-06-29 On-skin compositions and methods to relieve pain TR200003801T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/106,684 US6290986B1 (en) 1996-10-24 1998-06-29 Method and composition for transdermal administration of pharmacologic agents
US12290399P 1999-03-05 1999-03-05

Publications (1)

Publication Number Publication Date
TR200003801T2 true TR200003801T2 (en) 2001-06-21

Family

ID=26803907

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03801T TR200003801T2 (en) 1998-06-29 1999-06-29 On-skin compositions and methods to relieve pain

Country Status (18)

Country Link
EP (1) EP1093348A4 (en)
JP (1) JP2002519310A (en)
KR (1) KR20010078754A (en)
CN (1) CN1331576A (en)
AU (1) AU4841599A (en)
BG (1) BG105175A (en)
BR (1) BR9912508A (en)
CA (1) CA2335837A1 (en)
HR (1) HRP20000905A2 (en)
HU (1) HUP0102728A3 (en)
ID (1) ID28213A (en)
IL (1) IL140420A0 (en)
MX (1) MXPA00012767A (en)
NO (1) NO20006604L (en)
PL (1) PL345216A1 (en)
SK (1) SK20012000A3 (en)
TR (1) TR200003801T2 (en)
WO (1) WO2000000120A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572880B2 (en) * 1996-10-24 2003-06-03 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
WO1998047869A1 (en) 1997-04-22 1998-10-29 Cocensys, Inc. Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
DK1632234T3 (en) 1999-07-01 2007-09-17 Pharmacia & Upjohn Co Llc (S, S) reboxetine for the treatment of chronic fatigue syndrome
EP1459749B1 (en) * 1999-07-01 2005-10-05 Pharmacia & Upjohn Company LLC (S,S)-reboxetine for treating incontinence
AU1261501A (en) * 1999-12-06 2001-06-18 Stanley L. Gore Compositions and methods for intranasal delivery of active agents to the brain
IN191512B (en) * 2000-01-21 2003-12-06 Panacea Biotech
DE10032132A1 (en) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermal therapeutic system containing non-steroidal anti-inflammatory drugs with selective COX-2 inhibition
DE10042412B4 (en) * 2000-08-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag Transceiver for bus subscriber of bus system of building system engineering, has two wires, where microcontroller is connected with receiver unit over connection on one hand, which is connected to two wires of bus system
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP2218448B1 (en) 2002-12-13 2015-09-23 Durect Corporation Oral drug delivery system comprising high viscosity liquid carrier materials
JP2005154368A (en) * 2003-11-27 2005-06-16 Teikoku Seiyaku Co Ltd Analgesic agent for neuropathic pain containing disopyramide
JP4807721B2 (en) * 2004-01-29 2011-11-02 株式会社 メドレックス Anti-inflammatory analgesic topical
EP1809329B1 (en) 2004-09-17 2011-12-21 Durect Corporation Sustained local anesthetic composition containing saib
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
JP2007308403A (en) * 2006-05-17 2007-11-29 Kenji Yoshida Skin care preparation
KR100880748B1 (en) * 2006-08-29 2009-02-02 정헌택 Pharmaceutical composition containing demethoxycurcumin to prevent restenosis
US8337883B2 (en) 2006-11-03 2012-12-25 Durect Corporation Transdermal delivery systems
US9511016B2 (en) * 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain
JP2011506319A (en) 2007-12-06 2011-03-03 デュレクト コーポレーション Useful methods for the treatment of pain, joint inflammation symptoms, or inflammation associated with chronic diseases
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CN102421440B (en) * 2009-05-07 2017-06-09 东国制药（株） Pharmaceutical compositions for preventing or treating neurogenic pain
US8491927B2 (en) * 2009-12-02 2013-07-23 Nimble Epitech, Llc Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor
US9572885B2 (en) 2013-03-15 2017-02-21 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
AU2015217309A1 (en) * 2014-02-11 2016-08-25 Dr. Reddy's Laboratories Ltd. Parenteral compositions of celecoxib
BR112021007877A2 (en) 2018-10-26 2021-08-03 Viramal Limited mucoadhesive gel composition
CN115666621A (en) 2020-01-13 2023-01-31 度勒科特公司 Sustained release drug delivery systems with reduced impurities and related methods
FR3108841B1 (en) * 2020-04-06 2023-11-03 Algotherapeutix TOPICAL PHARMACEUTICAL COMPOSITION IN AQUEOUS GEL FORM COMPRISING AT LEAST AMITRIPTYLINE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4395420A (en) * 1981-12-09 1983-07-26 Bernstein Joel E Method and composition for treating pruritis
SI9300468A (en) * 1992-10-14 1994-06-30 Hoffmann La Roche Injectable composition for the sustained release of biologically active compounds
GB9315856D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
US5885597A (en) * 1997-10-01 1999-03-23 Medical Research Industries,Inc. Topical composition for the relief of pain

Also Published As

Publication number Publication date
BR9912508A (en) 2001-05-02
EP1093348A1 (en) 2001-04-25
JP2002519310A (en) 2002-07-02
BG105175A (en) 2001-11-30
AU4841599A (en) 2000-01-17
CA2335837A1 (en) 2000-01-06
HUP0102728A3 (en) 2002-12-28
WO2000000120A1 (en) 2000-01-06
PL345216A1 (en) 2001-12-03
KR20010078754A (en) 2001-08-21
EP1093348A4 (en) 2003-07-16
IL140420A0 (en) 2002-02-10
NO20006604L (en) 2001-02-28
WO2000000120A9 (en) 2000-03-30
ID28213A (en) 2001-05-10
HRP20000905A2 (en) 2001-08-31
NO20006604D0 (en) 2000-12-22
HUP0102728A2 (en) 2002-03-28
SK20012000A3 (en) 2001-08-06
CN1331576A (en) 2002-01-16
MXPA00012767A (en) 2002-08-09

Similar Documents

Publication Publication Date Title
TR200003801T2 (en) On-skin compositions and methods to relieve pain
TR200103186T2 (en) Quinoline derivatives as inhibitors of MEK enzymes
WO2002053187A3 (en) Methods and transdermal compositions for pain relief
YU49101A (en) Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ES2189235T3 (en) 6-REPLACED PHENYLPHENANTRIDINS.
TR200302242T2 (en) Pyrolopyrimidines as protein kinase inhibitors
DK1071474T3 (en) Substituted porphyrins
ATE238307T1 (en) SUBSTITUTED PORPHYRINS
MXPA05003501A (en) Methods for treating pain by administering a nerve growth factor antagonist and an opioid analgesic and compositions containing the same.
DE60137966D1 (en) ANILINOPYRIMIDINE DERIVATIVES AS "JNK PATHWAY INHIBITORS", COMPOSITIONS AND ASSOCIATED TREATMENT METHODS
TR200100918T2 (en) Inhibition of RAF kinase using aryl and heteroaryl substituted ureas
ATE334985T1 (en) COMPOUNDS, METHODS AND PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CELL DAMAGE SUCH AS DAMAGE TO NERVOUS OR VESSEL TISSUE
BG106020A (en) Inhibitors of impdh enzyme
EA200401284A1 (en) SUBSTITUTED BENZEZOLES AND THEIR APPLICATION AS RAF KINASE INHIBITORS AS AN INHIBITORS
AR024138A1 (en) INHIBITORS OF THE CELL PROLIFERATION
TR200200205T2 (en) Treating chronic pain using MEK inhibitors
TR200102499T2 (en) As a combination therapy in the treatment of neoplasia, a cyclooxygenase-2 inhibitor and a method of using one or more antineoplastic agents
TR200101335T2 (en) Pirazolopyrimidinone derivatives for the treatment of impotence
MXPA01007451A (en) Substituted porphyrins.
PL406680A1 (en) Tyrosine kinase inhibitors
ATE218854T1 (en) TREATMENT OF CARDIAC ARTHRY DISORDERS BY INHIBITING A MULTIFUNCTIONAL CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE
TR200200204T2 (en) Treating chronic pain using MEK inhibitors.
EA199900448A1 (en) Derivatives of 6-phenylpyridyl-2-amine, useful as NOS inhibitors
DK1392328T3 (en) Medication for protection in radiotherapy
TR200101756T2 (en) 4,5-pyrazinoxindoles as protein kinase inhibitors.